MAPT and Parkinson disease: In conclusion, we have identified a lncRNA which has an inhibitory effect on the expression of a major neurodegenerative gene, MAPT. The lncRNA may serve as a sensitive biomarker of disease state in PD, as well as a potential therapeutic target for inhibiting the expression of MAPT.